Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Neurocognitive dysfunction in cancer patients.

¹Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA.

Oncology (Williston Park, N.Y.)

|February 19, 2000

Summary

Cancer can cause cognitive impairments like memory loss and multitasking difficulties, alongside mood issues and fatigue. Thorough assessment is crucial for effective interventions to improve patient function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.

Psycho-oncology·2013

Same author

A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Journal of neuro-oncology·2011

Same author

Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes.

Critical reviews in oncology/hematology·2011

Same author

Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target.

British journal of cancer·2004

Same author

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

Molecular psychiatry·2002

Same author

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.

International journal of radiation oncology, biology, physics·2002

Area of Science:

Neuroscience
Oncology
Psychiatry

Background:

Cancer patients frequently experience neurocognitive deficits, impacting memory, attention, and multitasking abilities.
These cognitive issues often coexist with mood disturbances, fatigue, and pain, significantly affecting daily functioning.
The causes are multifactorial, including direct cancer effects on the central nervous system (CNS), indirect paraneoplastic disorders, and treatment-related brain changes.

Purpose of the Study:

To highlight the prevalence and diverse etiologies of neurocognitive and mood impairments in cancer patients.
To emphasize the importance of comprehensive patient assessment for these symptoms.
To underscore the need for targeted interventions to improve functional outcomes.

Main Methods:

Review of existing literature on cancer-related neurocognitive dysfunction.
Analysis of factors contributing to cognitive and mood disturbances in cancer patients.
Discussion of diagnostic approaches for assessing neurocognitive and behavioral problems.

Main Results:

Neurocognitive impairments are common in cancer patients, manifesting as memory loss, distractibility, and multitasking difficulties.
Mood disturbances, fatigue, and pain frequently accompany cognitive symptoms, further compromising patient function.
Etiologies include direct CNS cancer effects, paraneoplastic syndromes, cancer treatments, and pre-existing psychiatric or neurologic conditions.

Conclusions:

Comprehensive assessment of neurocognitive and mood symptoms is essential for cancer patients.
Understanding the diverse causes is key to developing effective interventions.
Appropriate interventions can help maximize patients' ability to perform usual activities.

Related Experiment Videos